1)  PrP~(Sc)
PrP~(Sc)
2)  Pr
Pr
1.
Simultaneous Analysis of La, Ce, Pr, Sm and Nd in Tea with ICP-OES;
ICP-OES法同时测定茶叶中La、Ce、Pr、Sm、Nd五种稀土元素
2.
Simultaneous determination of La and Pr by k-factor double-wavelength standard addition method;
k系数双波长标准加入法同时测定Pr和La
3.
Analysis and clinical significance of ER PR Ki67 and P53 expression in breast cancer;
ER PR Ki67 P53在乳腺癌中表达的相关分析及临床意义
3)  Pr(Ⅲ)
Pr(Ⅲ)
4)  Pr)
Pr)
5)  progesterone receptor
PR
1.
[Objective] To investigate the expression of HOXA11,estrogen receptor(ER) and progesterone receptor(PR) in human fallopian tube and ectopic pregnant fallopian.
[目的]探讨HOXA11在异位妊娠输卵管中的作用,以及与ER、PR的关系。
2.
Objective To investigate the effect of neoadjuvant chemotherapy on estrogen(ER) and progesterone receptor(PR) expression in breast cancer.
方法:应用免疫组化方法检测60例新辅助化疗治疗的乳腺癌和84例未术前化疗的乳腺癌标本化疗前或术前和术后ER、PR的表达情况,比较两组ER、PR表达变化的差异。
3.
The clinical significance of LRP16 and its association of expression with estrogen receptor (ER), progesterone receptor (PR) and E-cadherin in serous ovarian cancer were investigated.
目的:探讨LRP16在上皮性卵巢肿瘤中的定位,分析浆液性卵巢癌中LRP16与雌激素受体(estrogen receptor,ER)、孕激素受体(progesterone receptor,PR)、E-钙黏着蛋白(E-cadherin)表达间的相关性及临床意义。
6)  PR-A
PR-A
1.
Objective: To study the expression of PR-A and PR-B in breast cancers with positive PR and explore the correlation between clincopathological characteristics and the expression of PR-A and PR-B as well as their ratio.
目的:研究孕激素受体亚型PR-A、PR-B在PR阳性乳腺癌组织中的表达,探讨PR-A、PR-B以及PR-A与PR-B的比值(PR-A∶PRB)与临床病理参数之间的关系。
参考词条
补充资料:Ciba SC Irgafos P-EPQ
分子式:C68H92O4P2
分子量:1035
CAS号:119345-01-6

性质:本品为白色固体粉末,溶于醇类、二氯甲烷、氯仿、甲苯等有机溶剂,几乎溶于水。具可水解性。

制备方法:暂无

用途:暂无

说明:补充资料仅用于学习参考,请勿用于其它任何用途。